New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides

Related articles

1. Investigation of anti-SARS CoV-2 multimeric bicyclic peptide inhibitors in a range of pre-clinical therapeutic settings

   This article has 23 authors:

   1. Maximilian A. J. Harman
   2. Katherine U. Gaynor
   3. Guido Papa
   4. Simone Pellegrino
   5. Gustavo Arruda Bezerra
   6. Brian McGuinness
   7. Phillip Jeffrey
   8. Paul Beswick
   9. Steven Stanway
   10. Katerine van Rietschoten
   11. Liuhong Chen
   12. Ieva Drulyte
   13. Joanne Herriott
   14. Edyta Kijak
   15. Eduardo Gallardo Toledo
   16. Lee Tatham
   17. Parul Sharma
   18. Eleanor Bentley
   19. Jo Sharp
   20. Adam Kirby
   21. Andrew Owen
   22. James P Stewart
   23. Michael J. Skynner

2. Identification and characterization of a SARS-CoV-2 M ^pro G23 deletion ensitrelvir-resistant mutant

   This article has 13 authors:

   1. Yao Ma
   2. Chengjin Ye
   3. R. Rahisuddin
   4. Sara H. Mahmoud
   5. Anastasija Cupic
   6. Ahmed Magdy Khalil
   7. Esteban Castro
   8. Nathaniel Jackson
   9. Mahmoud Bayoumi
   10. Yogesh K. Gupta
   11. Adolfo Garcia-Sastre
   12. Richard K Plemper
   13. Luis Martinez-Sobrido

3. Computational Insights into Papain-Like Protease Inhibition: Antimicrobial Peptides as Potential Therapeutics Against SARS-CoV-2

   This article has 8 authors:

   1. Erenilson dos Santos Moreira
   2. Fabricio dos Santos Barbosa
   3. Jailan da Silva Sousa
   4. Hugo Mauricio Peña Mercado
   5. Tarcisio Silva Melo
   6. Sergio Siqueira
   7. Aristóteles Góes-Neto
   8. Bruno Silva Andrade